Learn More


 
MBA Tools
MBA Glossary

 


Anika Therapeutics, Inc. - ANIK - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Anika Therapeutics, Inc. - SIC # 2834

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 2834 http://www.anikatherapeutics.com/ 14.40 Stock Up +0.25

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Anika Therapeutics, Inc.

SGEN's Adcetris under FDA Review - May 16th, 2013 1:30 pm
Amgen to Set Up JV in China - May 14th, 2013 2:20 pm
ANIKA THERAPEUTICS INC Financials - May 11th, 2013 11:04 am
Disappointing 1Q Earnings for IART - May 10th, 2013 8:25 am
Wider-than-Expected Loss at Dynavax - May 7th, 2013 8:45 am
5 Stocks Ready to Break Out - Mar 22nd, 2013 12:23 pm


View All Current Headlines >>

Bookmark and Share
facebooktwitter